# Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

> **NCT01398072** · PHASE3 · UNKNOWN · sponsor: **University College, London** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD).

## Interventions

- **DRUG:** Moxifloxacin
- **DRUG:** Azithromycin
- **DRUG:** Doxycycline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01398072
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2013-01
- **Final completion:** 2013-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2012-06-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01398072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01398072, "Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01398072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*